Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Matthew Davis

4PUBLICATIONS

4CO-AUTHORS

Disease surveillanceNutritional scienceHealth economicsEpidemiological methods

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jan 08, 2026

Risk of Extrahepatic Cancer for Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the United States Medicare Population.

Yestle Kim, Dominic Nunag, Matthew Davis

|Nov 22, 2024

Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study.

Yestle Kim, Joseph Medicis, Matthew Davis

|Apr 28, 2021

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs.

Darshan Mehta, Matthew Davis, Andrew J Epstein

|Aug 18, 2020

Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice.

Darshan Mehta, Matthew Davis, Andrew J Epstein

Pageof 1

Frequent Collaborators

2 joint publications

Darshan Mehta

2 joint publications

Andrew J Epstein

2 joint publications

Yestle Kim

2 joint publications

Robert Gish

Frequent Collaborators

2 joint publications

Darshan Mehta

2 joint publications

Andrew J Epstein

2 joint publications

Yestle Kim

2 joint publications

Robert Gish

Top Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on : Jul 18, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on : May 16, 2019

See more related videos

Top Related Videos

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on : Jul 18, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Published on : Apr 16, 2019

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice

Published on : May 16, 2019

See more related videos